Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novo Nordisk A/S (NVO) vs White Mountains Insurance Group Ltd. Common Stock (WTM) Price & Performance

Novo Nordisk A/STrade
White Mountains Insurance Group Ltd. Common StockTrade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs White Mountains Insurance Group Ltd. Common Stock — how do they compare? Novo Nordisk A/S trades at $38.74 (market cap $169.24B), while White Mountains Insurance Group Ltd. Common Stock trades at $2,090 (market cap $5.01B). The key difference: Novo Nordisk A/S is far larger — about 33.8× White Mountains Insurance Group Ltd. Common Stock's market cap, and Novo Nordisk A/S pays the higher dividend (4.71%). Which is the better fit depends on your goals.

NVOWTM
Market Cap
$169.24B$5.01B
Volume
9,314,27319,324
Sector
HealthFinancials
52-Week High
$63.98$2.32K
52-Week Low
$35.29$1.85K
Typical Hold Time
116 Days—
Enterprise Value
$187.94B$5.84B
Dividend Yield
4.71%0.05%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novo Nordisk A/S

Novo Nordisk (NVO) trades at $38.06, down 1.35% on the day, with bearish technical signals despite strong fundamentals. The company maintains exceptional profitability with 35.35% net margins and 59.82% ROE, while recent quarterly earnings consistently beat expectations. Technical indicators show oversold conditions with RSI at 85.35, though the stock faces resistance at $39 levels. Recent news highlights pipeline developments including Wegovy pill data and FDA reviews of hemophilia treatments.

NVO presents a compelling value opportunity with a 9.67 P/E ratio below industry averages and 58.98% analyst buy ratings targeting $42.33. Strong cash flow generation ($119.1B operating cash flow) supports dividend payments and strategic acquisitions. Key risks include competitive pressure from Eli Lilly's obesity drug pipeline and regulatory delays, but the company's dominant GLP-1 market position and expanding oral formulations provide growth catalysts.

White Mountains Insurance Group Ltd. Common Stock

White Mountains Insurance Group (WTM) trades at $2,093.13, up 0.31% with neutral technical signals. The stock shows strong fundamentals with a P/E of 4.8 and ROE of 21.9%, though recent earnings were mixed with Q2 2026 beating estimates while Q1 missed. Book value per share reached $2,258 as of June 2026, up 4% quarterly. Recent product launches and board additions signal strategic growth initiatives.

WTM presents value investment appeal with attractive valuation multiples and solid profitability, but faces execution risks from volatile quarterly earnings and negative cash flow trends. Analyst consensus remains neutral with 100% hold ratings, suggesting cautious optimism pending clearer earnings consistency and cash flow improvement.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NVO
68% Buy32% Sell
Avg holding period · 116 Days
WTM

No sentiment data available yet.

Top news

Latest headlines on both assets

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO →

About White Mountains Insurance Group Ltd. Common Stock

White Mountains Insurance Group Ltd. is a Bermuda-based holding company that owns and builds insurance and financial services businesses. Its operating segments include Ark, a specialty insurance and reinsurance underwriter; HG Global, which reinsures municipal bond insurer Build America Mutual; and Kudu Investment Management, which provides capital to boutique asset managers.

Read more on WTM →